from Medtronic, a global leader in healthcare technology, today launched the "Aortic Stenosis Patient Activation Platform", an end-to-end digital platform for patient awareness, patient education, and patient activation specific to aortic valve...
PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, announced the Nature publication1 of Gennova Biopharmaceutical’s Phase 2/3 clinical trial conducted to evaluate the...
and a wide range of surgical procedures. The veterinary hemostatic agent is made of two plant-based polysaccharides that form an instant mechanical barrier to stop bleeding on contact. Once the bleeding is controlled, VETIGEL can be easily removed...
to revolutionize patient care through multi-specific biologic treatments. The compelling science behind the Tentacles™ platform presents an unparalleled opportunity to impact the lives of patients globally. I am committed to harnessing this...
to promote health and improve lives. Factor Bioscience is privately held and headquartered in Cambridge, MA. For more information, visit www.factorbio.com.
medicine, announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™. Platform, and the first company to make comprehensive genomic profiling and liquid biopsy widely available to patients throughout...
Hyalex Orthopaedics, a privately held medical device company developing cartilage repair products based on the transformative HYALEX® materials platform, announced that patients have successfully received HYALEX Knee Implants as part of the...
natural immune system to defeat cancers and infectious diseases. The company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection...
clients, Cell Q™ includes a pre-qualified set of the most common assays. Additionally, each Cell Q™ utilizes a modular platform that can be expanded with new instruments providing the flexibility needed to meet varying IDMO client needs. Setting a...
for evaluation in clinical trials. Renibus has three additional assets at earlier stages of development. For more information, please visit www.Renibus.com
treatment of viruses, as well as cancer indications including brain tumors, pancreatic and other cancers. For more information please visit www.moleculin.com
the DxI 9000 Analyzer's capability to develop increasingly sensitive and clinically relevant assays, enabling the platform to keep pace with today's needs and tomorrow's testing requirements as healthcare providers strive to detect evermore...
BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory...
the publication of a study titled “Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: a 24-week, randomized, double-blind, active-controlled, phase 3 trial”...
consisting of unmodified, donor-derived gamma delta T cells, Deltacel™ is the leading candidate in Kiromic’s GDT platform. Deltacel™ is designed to exploit the natural potency of GDT cells to target solid cancers, with an initial clinical focus on...
to offer the same safety and efficacy profile as SABRIL® (vigabatrin) for oral solution. Please see full Prescribing Information to view other approved indications, BOXED WARNINGS, and Important Safety Information. nfantile spasms, a rare but...
healthy blood sugar, insulin, hormone, and lipid levels, plus healthy body composition and metabolism.* Gut-Friendly Formula: Promotes a healthy gut microbiome to promote digestive and overall health.* Superior Absorption: Berberine’s many benefits...
by its attentive level of service, strong industry relationships, and dedication to uninterrupted supply. For more information, visit www.upsher-smith.com.
Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND)....
pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit www.neurocrine.com
